Caplin Point Laboratories Limited (CAPLIPOINT:NSE) Stock Forecast
Alert
Its only available to paid users.
INR 1,605.00
(+23.58%)
Based on the Caplin Point Laboratories Limited stock forecast from 2 analysts, the average analyst target price for Caplin Point Laboratories Limited is INR 1,605.00 over the next 12 months. Caplin Point Laboratories Limited’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Caplin Point Laboratories Limited is Slightly Bullish , which is based on 8 positive signals and 4 negative signals. At the last closing, Caplin Point Laboratories Limited’s stock price was INR 1,298.75. Caplin Point Laboratories Limited’s stock price has changed by -4.19% over the past week, -1.27% over the past month and +89.61% over the last year.
Analyst Ratings
Target Price Action
Rating Action
Analyst
Rating
Price
Date
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Add to Watchlists
loading..
Download Confirmation
Premium customers can only download records visible on the current page view, while Platinum customers can download the first 1000 records.
Paid-only feature
CSV downloads are only available for paying customers.
Thank you for Sharing your Stock Targets for CAPLIPOINT:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
